• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

1.960 -0.020 (-1.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 83,667
Open 1.960
Bid (Size) 2.000 (200)
Ask (Size) 2.040 (900)
Prev. Close 1.980
Today's Range 1.930 - 2.040
52wk Range 1.710 - 17.64
Shares Outstanding 596,978
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003
June 02, 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003
May 19, 2026
From Enveric Biosciences
Via Business Wire

Performance

YTD
-46.6%
-46.6%
1 Month
-43.7%
-43.7%
3 Month
-1.0%
-1.0%
6 Month
-67.9%
-67.9%
1 Year
-87.3%
-87.3%

More News

Read More
News headline image
Enveric Biosciences Reports Financial Results and Provides Corporate Update for First Quarter 2026
May 15, 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders
May 13, 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model
May 05, 2026
From Enveric Biosciences
Via Business Wire
These stocks are moving in today's session ↗
April 30, 2026
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
April 30, 2026
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
April 30, 2026
Via Chartmill
News headline image
SmallCap Emerge: ENVB, SMX, ANY, ELPW Across High-Growth Sectors
April 24, 2026
Via AB Newswire
Topics Artificial Intelligence Economy
Top movers analysis one hour before the close of the markets on 2026-04-24: top gainers and losers in today's session. ↗
April 24, 2026
Via Chartmill
News headline image
Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum
April 21, 2026
From Enveric Biosciences
Via Business Wire
News headline image
Kartoon Studios (NYSE: TOON) Gaining Momentum Alongside CMND, ENVB, WLDS, ANY – See Why?
April 20, 2026
Via AB Newswire
Topics Intellectual Property
Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session. ↗
April 20, 2026
Via Chartmill
These stocks are the most active in today's session ↗
April 20, 2026
Via Chartmill
Unusual volume stocks are being observed in Monday's session. ↗
April 20, 2026
Via Chartmill
What's going on in today's session ↗
April 20, 2026
Via Chartmill
Top movers in Monday's pre-market session ↗
April 20, 2026
Via Chartmill
News headline image
Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules
April 17, 2026
From Enveric Biosciences, Inc.
Via Business Wire
Which stocks are experiencing notable movement on Friday? ↗
April 17, 2026
Via Chartmill
These stocks have an unusual volume in today's session ↗
April 17, 2026
Via Chartmill
Friday's session: top gainers and losers ↗
April 17, 2026
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
April 17, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
April 17, 2026
Via Chartmill
News headline image
Enveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules
April 16, 2026
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates
March 31, 2026
From Enveric Biosciences
Via Business Wire

Frequently Asked Questions

Is Enveric Biosciences, Inc. - Common Stock publicly traded?
Yes, Enveric Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Enveric Biosciences, Inc. - Common Stock trade on?
Enveric Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Enveric Biosciences, Inc. - Common Stock?
The ticker symbol for Enveric Biosciences, Inc. - Common Stock is ENVB on the Nasdaq Stock Market
What is the current price of Enveric Biosciences, Inc. - Common Stock?
The current price of Enveric Biosciences, Inc. - Common Stock is 1.960
When was Enveric Biosciences, Inc. - Common Stock last traded?
The last trade of Enveric Biosciences, Inc. - Common Stock was at 06/04/26 04:00 PM ET
What is the market capitalization of Enveric Biosciences, Inc. - Common Stock?
The market capitalization of Enveric Biosciences, Inc. - Common Stock is 1.17M
How many shares of Enveric Biosciences, Inc. - Common Stock are outstanding?
Enveric Biosciences, Inc. - Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap